Fighting skin cancers with computers and technology

NEW YORK, June 1999 - Memorial Sloan-Kettering's new Laurance S. Rockefeller Outpatient Pavilion will house the country's first fully computerized photography system to follow patients at risk for melanoma, a deadly skin cancer. Each year, individuals with irregularly shaped moles called "dysplastic nevi" are at risk of becoming one of the 42,000 people who will be diagnosed with melanoma. Although these pigmented lesions cannot all be removed as a preventive measure because they can be so numerous, they must be closely monitored.

Allan Halpern, M.D., Chief of the Dermatology Service at Memorial Sloan- Kettering, has established a Digital Imaging Screening program that uses computerized photography for follow-up screening of patients with a large number of dysplastic moles. A digital photographic record of each of the patient's moles is created and stored. When the patient returns for subsequent appointments, any suspected change to a mole can be verified by an immediate comparison to the computerized photographic record. The baseline image can be retrieved and the mole in question observed in close-up view. This takes away any guesswork in identifying the mole or verifying any alteration. If there is in fact a change and the mole has become malignant, the dermatologist is able to make the diagnosis at the earliest possible time.

Memorial Sloan-Kettering's new outpatient pavilion will also provide a full range of dermatology services including Mohs' surgery, a leading-edge micrographic treatment for non-melanoma skin cancers that are associated with high-risk local recurrence. These non-melanoma skin cancers, including basal- cell carcinoma and squamous-cell carcinoma, often occur on the face, where incomplete removal of these skin cancers can lead to regrowth and significant disfigurement, and can become serious medical problems.

Kishwer Nehal, M.D., Director of the Mohs' Surgery Program a

Contact: Avice Meehan or Christine Westerman
Memorial Sloan-Kettering Cancer Center

Page: 1 2

Related biology news :

1. Fighting Mycobacterium tuberculosis with structural proteomics
2. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
3. Fighting the spread of sudden oak death
4. Fighting the battle of the bulge in children
5. Fighting breast cancer at the molecular level
6. Fighting Fungi
7. Fighting diabetes: UD researchers move closer to chip-based control of smart, implantable insulin pumps
8. Trash From Crop-Processing Plant Harvested For Disease-Fighting Agents
9. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
10. Chemical Contaminants May Inhibit Cancer-Fighting White Blood Cells
11. Radioactive Beads Latest Weapon In Fighting Cancer In Dogs, Cats

Post Your Comments:

(Date:5/31/2019)... ... May 30, 2019 , ... Enso Discoveries Chief Executive Officer, Patrick Farley, is ... as a way to express his gratitude and respect for those who have served ... Enso Discoveries — presented a check for $1,000 to the Green Beret ...
(Date:5/24/2019)... (PRWEB) , ... May 24, 2019 , ... The newest ... and is now available on the company’s global website. , Crystallography Times is a ... crystal X-ray diffraction. It serves the X-ray analysis community by presenting the latest news ...
(Date:5/23/2019)... SAN FRANCISCO (PRWEB) , ... May 23, 2019 ... ... Intelligent Virtual Agents for sales and service organizations, today announced its ... report identifies Inference Solutions as the intelligent virtual agent (IVA) market share leader, ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally recognized ... provides Object exclusive ownership and commercialization rights to a full spectrum of botulinum ...
Breaking Biology Technology:
Cached News: